Virus-induced ROS production can lead to decreased glutathione (GSH) levels and activation of the antioxidant defense system including catalase (CAT) and superoxide dismutase (SOD1), as seen in COVID-19 patients (61). The gene discussed is CAT; the disease is COVID-19.